USP9 Antibodies

Santa Cruz Biotechnology provides a broad selection of USP9 monoclonal antibodies for research focused on understanding USP9 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). USP9, or Ubiquitin-Specific Protease 9, is a deubiquitinating enzyme that plays a critical role in regulating protein stability and cellular signaling pathways. USP9 is involved in various cellular processes, including cell cycle regulation, apoptosis, and DNA repair, making it an important target for cancer research and therapeutic development. Understanding USP9 function is essential for elucidating its contributions to disease mechanisms and potential treatment strategies. Researchers worldwide rely on USP9 monoclonal antibodies to advance their studies in protein degradation pathways. Current investigations utilizing USP9 monoclonal antibodies are uncovering new insights into cancer biology and therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies for USP9 continue to support breakthrough discoveries in cellular and molecular biology research.